114 related articles for article (PubMed ID: 839976)
1. Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects.
Ogihara T; Matsumura S; Onishi T; Miyai K; Uozumi T
Life Sci; 1977 Feb; 20(3):523-6. PubMed ID: 839976
[No Abstract] [Full Text] [Related]
2. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
3. Hyper-responsiveness of aldosterone to metoclopramide in aldosteronism.
Gniadek TC; Grekin RJ; Gross MD; Villareal JZ
Clin Endocrinol (Oxf); 1982 May; 16(5):475-81. PubMed ID: 7044619
[No Abstract] [Full Text] [Related]
4. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
[TBL] [Abstract][Full Text] [Related]
5. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
Nagahama S; Fujimaki M; Kawabe H; Nakamura R; Saito I; Saruta T
Clin Endocrinol (Oxf); 1983 Mar; 18(3):287-93. PubMed ID: 6861367
[TBL] [Abstract][Full Text] [Related]
6. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
8. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
[No Abstract] [Full Text] [Related]
9. Effect of metergoline on the aldosterone-stimulating properties of metoclopramide.
Opocher G; Murgia A; Boscaro M; D'Agostino D; Fallo F; Mantero F
J Steroid Biochem; 1983 Jul; 19(1B):531-6. PubMed ID: 6350721
[TBL] [Abstract][Full Text] [Related]
10. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)].
Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824
[No Abstract] [Full Text] [Related]
11. Effect of metoclopramide on aldosterone and regulatory factors in man.
Gilchrist NL; Espiner EA; Nicholls MG; Donald RA
Clin Endocrinol (Oxf); 1984 Jul; 21(1):1-7. PubMed ID: 6086181
[TBL] [Abstract][Full Text] [Related]
12. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
Sowers JR; Glub MS; Eggena PH; Catania RA
J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
[TBL] [Abstract][Full Text] [Related]
13. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies on the effect of metoclopramide on aldosterone secretion.
Edwards CR; Al-Dujaili EA; Boscaro M; Quyyumi S; Miall PA; Rees LH
Clin Endocrinol (Oxf); 1980 Jul; 13(1):45-50. PubMed ID: 7438463
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of metoclopramide on plasma aldosterone concentrations in young calves.
Safwate A; Tournaire C; Dalle M; Barlet JP
J Physiol (Paris); 1985; 80(5):336-9. PubMed ID: 3831326
[TBL] [Abstract][Full Text] [Related]
16. [Lack of effect of aging on dopaminergic inhibition of aldosterone and prolactin increase].
Preis P; Luger A; Templ H; Tragl HK; Geyer G
Z Gerontol; 1985; 18(4):241-3. PubMed ID: 3901563
[TBL] [Abstract][Full Text] [Related]
17. Interference by ranitidine with aldosterone secretion in vivo.
Sancho JM; Garcia Robles R; Mancheño E; Paya C; Rodicio JL; Ruilope L
Eur J Clin Pharmacol; 1984; 27(4):495-7. PubMed ID: 6097456
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism.
Golub MS; Sowers JR; Eggena P; Baron SH
Metabolism; 1982 Jul; 31(7):740-3. PubMed ID: 7045577
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of metoclopramide on aldosterone secretion in rats.
Nagahama S; Fujimaki M; Suzuki H; Kawabe H; Saito I; Saruta T
Acta Endocrinol (Copenh); 1983 Apr; 102(4):589-93. PubMed ID: 6342328
[TBL] [Abstract][Full Text] [Related]
20. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
